Trade MDWD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
MediWound Ltd. (MDWD) is trading at US$12.66, down 4.38% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$170.54M. Over the past 52 weeks, MDWD has traded between US$12.52 and US$20.30. On Syfe you can trade MDWD with $0 commission and add it to your watchlist.
| Previous close | US$13.24 |
|---|---|
| Market cap | US$170.54M |
| 52-week range | US$12.52 – US$20.30 |
| Volume | 165.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MediWound Ltd.
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
Year: 2014
Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating
May 28, 1:02 PM · MT Newswires
MediWound Ltd. (MDWD) stock is trading at US$12.66, -4.38% from the previous close of US$13.24.
The market cap for MediWound Ltd. (MDWD) stock is approximately US$170.54M.
The 52-week high for MediWound Ltd. (MDWD) stock is US$20.30.
The 52-week low for MediWound Ltd. (MDWD) stock is US$12.52.
MediWound Ltd. (MDWD) does not currently pay a dividend.
Stay on top of MDWD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
